Epidemiology of ameloblastomas of the jaw: a report from the Netherlands
NAGIOS: RODERIC FUNCIONANDO

Epidemiology of ameloblastomas of the jaw: a report from the Netherlands

DSpace Repository

Epidemiology of ameloblastomas of the jaw: a report from the Netherlands

Show simple item record

dc.contributor.author Oomens, Marjolijn A.E.M. es
dc.contributor.author Van der Waal, Isaäc es
dc.date.accessioned 2015-01-08T12:34:42Z
dc.date.available 2015-01-08T12:34:42Z
dc.date.issued 2014 es
dc.identifier.uri http://hdl.handle.net/10550/41158
dc.relation http://www.medicinaoral.com/pubmed/medoralv19_i6_p581.pdf es
dc.source Oomens, Marjolijn A.E.M. ; Van der Waal, Isaäc. Epidemiology of ameloblastomas of the jaw: a report from the Netherlands. En: Medicina oral, patología oral y cirugía bucal. Ed inglesa, 2014, Vol. 19, No. 6: 581-583 es
dc.subject Odontología es
dc.subject Ciencias de la salud es
dc.title Epidemiology of ameloblastomas of the jaw: a report from the Netherlands es
dc.type info:eu-repo/semantics/article en
dc.type info:eu-repo/semantics/publishedVersion en
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.description.abstractenglish Objectives: To provide epidemiological data of ameloblastomas of the jaws in the Netherlands over a 25-year time period (1985-2010) and to compare these data with data from other parts of the world. Material and Methods: The data of all patients diagnosed with a primary ameloblastoma of the jaws in the Nether - lands in the period 1985-2010 have been retrieved from the nationwide histopathology and cytopathology network and registry in the Netherlands (PALGA). The pathology reports were screened and only those cases were included in which a distinct diagnosis of primary, histopathologically benign, intraosseous ameloblastoma was rendered. The average population in The Netherlands during this period amounted approximately 15 million people. Results: An annual incidence rate was approximately 1,5 per million population, the male-female ratio being 1.4: 1. The age at the time of diagnosis was 44.1 years. The average age in males was 46.3 years compared to an aver - age age in females of 41.3 years, the difference being significant (p≤ 0.05). The results were compared with those available in only a small number of publications worldwide. Conclusions: There is no strong evidence for significant differences of the true incidence of ameloblastomas worldwide, neither for a gender predilection. The diagnosis is generally made at a somewhat lower age in women; this phenomenon is even much stronger in the Black population, irrespective of gender. No proper explanation for this finding can be provided. es

View       (348.0Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics